# Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

> **NCT00260026** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 20 (—)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Jin Fu Kang

## Key facts

- **NCT ID:** NCT00260026
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260026, "Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00260026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*